Mindfulness-based cognitive therapy to prevent relapse in recurrent depression.

For people at risk of depressive relapse, mindfulness-based cognitive therapy (MBCT) has an additive benefit to usual care (H. F. Coelho, P. H. Canter, & E. Ernst, 2007). This study asked if, among patients with recurrent depression who are treated with antidepressant medication (ADM), MBCT is comparable to treatment with maintenance ADM (m-ADM) in (a) depressive relapse prevention, (b) key secondary outcomes, and (c) cost effectiveness. The study design was a parallel 2-group randomized controlled trial comparing those on m-ADM (N = 62) with those receiving MBCT plus support to taper/discontinue antidepressants (N = 61). Relapse/recurrence rates over 15-month follow-ups in MBCT were 47%, compared with 60% in the m-ADM group (hazard ratio = 0.63; 95% confidence interval: 0.39 to 1.04). MBCT was more effective than m-ADM in reducing residual depressive symptoms and psychiatric comorbidity and in improving quality of life in the physical and psychological domains. There was no difference in average annual cost between the 2 groups. Rates of ADM usage in the MBCT group was significantly reduced, and 46 patients (75%) completely discontinued their ADM. For patients treated with ADM, MBCT may provide an alternative approach for relapse prevention.

[1]  R. Kessler,et al.  Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. , 1997, Journal of affective disorders.

[2]  M J Al,et al.  Costs, effects and C/E-ratios alongside a clinical trial. , 1994, Health economics.

[3]  M. Posternak,et al.  How should remission from depression be defined? The depressed patient's perspective. , 2006, The American journal of psychiatry.

[4]  D. Bhugra,et al.  Why people do not take their psychotropic drugs as prescribed: results of the 2000 National Psychiatric Morbidity Survey , 2007, Acta psychiatrica Scandinavica.

[5]  D. Kupfer,et al.  Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review , 2003, The Lancet.

[6]  Z. Segal,et al.  Mindfulness-Based Cognitive Therapy for Depression: A New Approach to Preventing Relapse , 2001 .

[7]  M. Thase,et al.  The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. , 1997, JAMA.

[8]  M. Kenward,et al.  An Introduction to the Bootstrap , 2007 .

[9]  M. Kovács.  Cognitive therapy in depression. , 1980, The Journal of the American Academy of Psychoanalysis.

[10]  L. Judd.  The clinical course of unipolar major depressive disorders. , 1997, Archives of general psychiatry.

[11]  Z. Segal,et al.  The mindfulness‐based cognitive therapy adherence scale: inter‐rater reliability, adherence to protocol and treatment distinctiveness , 2002 .

[12]  Wayne Katon,et al.  Cost-effectiveness of collaborative care for depression in a primary care veteran population. , 2003, Psychiatric services.

[13]  G. Fava,et al.  Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. , 1998, The American journal of psychiatry.

[14]  S. Saxena,et al.  The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. , 1995, Social science & medicine.

[15]  J. Teasdale,et al.  Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. , 2004, Journal of consulting and clinical psychology.

[16]  D. Goldberg.  Psychiatry and primary care. , 2003, World psychiatry : official journal of the World Psychiatric Association.

[17]  Janet B W Williams,et al.  A structured interview guide for the Hamilton Depression Rating Scale. , 1988, Archives of general psychiatry.

[18]  W. Katon,et al.  Epidemiology of depression in primary care. , 1992, General hospital psychiatry.

[19]  J. H. Kamphuis,et al.  Preventing relapse/recurrence in recurrent depression with cognitive therapy: a randomized controlled trial. , 2005, Journal of consulting and clinical psychology.

[20]  L. Curtis,et al.  Unit Costs of Health and Social Care 2016 , 2015 .

[21]  E. Ernst,et al.  Mindfulness-based cognitive therapy: evaluating current evidence and informing future research. , 2007, Journal of consulting and clinical psychology.

[22]  M. Sculpher,et al.  Representing uncertainty: the role of cost-effectiveness acceptability curves. , 2001, Health economics.

[23]  M. Power,et al.  Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment , 1998 .

[24]  M. Olfson,et al.  Continuity of antidepressant treatment for adults with depression in the United States. , 2006, The American journal of psychiatry.

[25]  S. Skevington,et al.  The World Health Organization's WHOQOL-BREF quality of life assessment: Psychometric properties and results of the international field trial. A Report from the WHOQOL Group , 2004, Quality of Life Research.

[26]  D. Kupfer,et al.  Continuation drug therapy for major depressive episodes: how long should it be maintained? , 1986, The American journal of psychiatry.

[27]  Z. Segal,et al.  Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. , 2000, Journal of consulting and clinical psychology.

[28]  A. B. Prasad,et al.  British National Formulary , 1994 .

[29]  R. Baer.  Mindfulness Training as a Clinical Intervention: A Conceptual and Empirical Review , 2003 .

[30]  A. Beekman,et al.  Patients' preferences in the treatment of depressive disorder in primary care. , 2004, General hospital psychiatry.

[31]  S. Thompson,et al.  How should cost data in pragmatic randomised trials be analysed? , 2000, BMJ : British Medical Journal.

[32]  M. Paulus,et al.  The role of residual subthreshold depressive symptoms in early episode relapse in unipolar major depressive disorder. , 1999, Archives of general psychiatry.

[33]  David J Miklowitz,et al.  Psychosocial intervention development for the prevention and treatment of depression: promoting innovation and increasing access , 2002, Biological Psychiatry.

[34]  J. Laurenceau,et al.  Some methodological and statistical issues in the study of change processes in psychotherapy. , 2007, Clinical psychology review.

[35]  Nice.  Depression: management of depression in primary and secondary care , 2005 .

[36]  David C. Atkins,et al.  Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. , 2006, Journal of consulting and clinical psychology.

[37]  K Claxton,et al.  The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. , 1999, Journal of health economics.

[38]  Jürgen Unützer,et al.  Cost-Effectiveness of a Program to Prevent Depression Relapse in Primary Care , 2002, Medical care.

[39]  Z. Segal,et al.  Teasdale's differential activation hypothesis: implications for mechanisms of depressive relapse and suicidal behaviour. , 2004, Behaviour research and therapy.

[40]  R. DeRubeis,et al.  Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. , 2005, Archives of general psychiatry.

[41]  Nicole Lee,et al.  The Mindful Way Through Depression: Freeing Yourself from Chronic Unhappiness , 2009 .

[42]  M. Knapp,et al.  Evidence of cost-effective treatments for depression: a systematic review. , 2005, Journal of affective disorders.

[43]  J. Teasdale,et al.  Prevention of relapse in residual depression by cognitive therapy: a controlled trial. , 1999, Archives of general psychiatry.

[44]  W. Shadish,et al.  Empirically supported treatments or type I errors? Problems with the analysis of data from group-administered treatments. , 2005, Journal of consulting and clinical psychology.

[45]  K. Dobson,et al.  Cognitive therapy of depression: pretreatment patient predictors of outcome. , 2002, Clinical psychology review.

[46]  W. Katon,et al.  A randomized trial of relapse prevention of depression in primary care. , 2001, Archives of general psychiatry.

[47]  Dc Washington.  Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .

[48]  R. Byng,et al.  Under/over‐recruitment to mental health trials , 2007, Acta psychiatrica Scandinavica.

[49]  G. Klerman,et al.  Long-term outcome of episodes of major depression. Clinical and public health significance. , 1984, JAMA.

[50]  W. Katon,et al.  Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. , 2001, The American journal of psychiatry.

[51]  J. Kabat-Zinn,et al.  Full catastrophe living : how to cope with stress, pain and illness using mindfulness meditation , 2004 .

[52]  L. Green,et al.  Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence , 1986, Medical care.

[53]  D. Kupfer,et al.  Five-year outcome for maintenance therapies in recurrent depression. , 1990, Archives of general psychiatry.

[54]  O C Ukoumunne,et al.  Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a decision-making approach , 2003, Psychological Medicine.

[55]  D J Kupfer,et al.  Three-year outcomes for maintenance therapies in recurrent depression. , 1990, Archives of general psychiatry.